Selected
Type of publications
Topics
Regions
Countries
Diseases
Publication date
Target population
Available to download in languages
1144 results found
2023 ∙ Eiden, Amanda L. Barratt, Jane Nyaku, Mawuli K.
A review of factors influencing vaccination policies and programs for older adults globally
  • Acceptance
  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Herpes zoster
  • Tetanus
Rating:
Not applicable
2023 ∙ Xu, K. Wang, Z. Qin, M. Gao, Y. Luo, N. Xie, W. Zou, Y. Wang, J. Ma, X.
A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults
  • Vaccine/vaccination
  • Efficacy/effectiveness
  • Safety
  • Adults
  • Older adults
  • COVID-19
Rating:
Critically low
2023 ∙ Jagne, Isatou von Mollendorf, Claire Wee-Hee, Ashleigh Ortika, Belinda Satzke, Catherine Russell, Fiona M.
A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of age
  • Efficacy/effectiveness
  • Newborn
  • Children
  • Pneumococcal disease
Rating:
Low
2023 ∙ Ayyalasomayajula, S. Dhawan, A. Karattuthodi, M. S. Thorakkattil, S. A. Abdulsalim, S. Elnaem, M. H. Sridhar, S. Unnikrishnan, M. K.
A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population
  • Vaccine/vaccination
  • Acceptance
  • Adults
  • Older adults
  • COVID-19
Rating:
Not applicable
2023 ∙ Alhandod, T. A. Rabbani, S. I. Almuqbil, M. Alshehri, S. Hussain, S. A. Alomar, N. F. Mir, M. A. Asdaq, S. M. B.
A Systematic Review on the Safety and Efficacy of COVID-19 Vaccines Approved in Saudi Arabia
  • Vaccine/vaccination
  • Efficacy/effectiveness
  • Safety
  • Adults
  • Older adults
  • Saudi Arabia
  • COVID-19
Rating:
Critically low
2023 ∙ Segal, H. A. Rashid, N.
A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries
  • Economic aspects
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
Rating:
Not applicable
2023 ∙ Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
  • Economic aspects
  • Newborn
  • Children
  • Adolescents
  • Adults
  • Pneumococcal disease
  • Rotavirus
  • Human papillomavirus (HPV)
  • Meningococcal disease
  • Mumps
  • Measles
  • Rubella
Rating:
Not applicable
2023 ∙ Dadari, I. Belt, R. V. Iyengar, A. Ray, A. Hossain, I. Ali, D. Danielsson, N. Sodha, S. V.
Achieving the IA2030 Coverage and Equity Goals through a Renewed Focus on Urban Immunization
  • Coverage
  • Ethical issues
  • Newborn
  • Children
  • Adolescents
Rating:
Not applicable
2023 ∙ Amisha, F. Saluja, P. Malik, P. Van Rhee, F.
Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: A systematic review
  • Vaccine/vaccination
  • Safety
  • Adults
  • Older adults
  • COVID-19
Rating:
Critically low
2023 ∙ Nabizadeh, F. Noori, M. Rahmani, S. Hosseini, H.
Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review
  • Vaccine/vaccination
  • Safety
  • Adults
  • Older adults
  • COVID-19
Rating:
Critically low